Role of inflammatory cells in the kidney in the induction and maintenance of hypertension

Nephrology Dialysis Transplantation

Volumn 21, Issue 2, 2006, Pages 260-263

  Rodriguez Iturbe, Bernardo ^a   Johnson, Richard J ^b  

^a HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Hypertension; Inflammation

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BOVINE SERUM ALBUMIN; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N(G) NITROARGININE METHYL ESTER; REACTIVE OXYGEN METABOLITE; SODIUM;

DIURESIS; EDITORIAL; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; KIDNEY DISEASE; KIDNEY INTERSTITIUM; NEPHRITIS; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; SODIUM EXCRETION; SODIUM RETENTION;

ANIMALS; HUMANS; HYPERTENSION; KIDNEY; LYMPHOCYTES; MACROPHAGES; NEPHRITIS;

EID: 31544450997     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi319     Document Type: Editorial

References (30)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005; 365: 217-223
2. Guyton AC, Coleman TG, Cowley AV Jr, Scheel KW, Manning RD Jr, Normal RA Jr. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972; 52: 584-594
3. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells and salt-sensitive hypertension: All for one and one for all. Am J Physiol Renal Physiol 2004; 286: 17606-17616
4. Rudolf Virchow. Lecture XVII Cellular Pathology, Twenty Lectures (translated by Frank Chance). John Churchill, London, 1860: 393-394
5. Kimmelsteil P, Wilson C. Benign and malignant hypertension and nephrosclerosis. A clinical and pathological study. Am J Pathol 1936; 12: 45-81
6. Caetano EP, Zatz R, Praxedes JN. The clinical diagnosis of hypertensive nephrosclerosis: How reliable is it? Nephrol Dial Transplant 1999; 14: 288-290
7. Weiss S, Parker F. Pyelonephritis: Its relation to vascular lesions and to arterial hypertension. Medicine 1939; 18: 221-315
8. Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH. Hyperuricemia in primary and renal hypertension. N Engl J Med 1966; 275: 457-464
9. Kuster G, Ritz E. Analgesic abuse and hypertension. Lancet 1989; 2: 1105
10. Curtis JJ, Luke RG, Jones P, Diethelm AG. Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent. Am J Med 1988; 85: 134-138
11. Müller DN, Dechend R, Mervaala EM et al. NF-κB inhibition ameliorates angiotensin II-induced renal damage in rats. Hypertension 2000; 35: 193-201
12. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 2003: 41: 341-346
13. Rodriguez-Iturbe B, Quiroz Y, Nava M et al. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 2002; 282: F191-F201
14. Vanegas V, Ferrebuz A, Quiroz Y, Rodriguez-Iturbe B. Hypertension in Page (cellophane wrapped) kidney is due to interstitial nephritis. Kidney Int 2005; 68: 1161-1170
15. Rodríguez-Iturbe B, Pons H, Quiroz Y et al. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 2001; 59: 2222-2232
16. Quiroz Y, Pons H, Gordon KL et al. Mycophenolate mofetil prevents the salt-sensitive hypertension resulting from short-term nitric oxide synthesis inhibition. Am J Physiol Renal Physiol 2001; 281: F38-F47
17. Alvarez V, Quiroz Y, Nava M, Pons H, Rodriguez-Iturbe B. Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol Renal Physiol 2002; 283: F1132-F1141
18. Rodriguez-Iturbe B, Quiroz Y, Ferrebuz A, Parra G, Vaziri ND. Evolution of renal interstitial inflammation and NF-κB activation in spontaneously hypertensive rats. Am J Nephrol 2004; 24: 587-594
19. Dröge W. Free radicals in the physiologic control of cell function. Physiol Rev 2002; 82: 47-95
20. Wilcox CS, Welch WJ. Oxidative stress: Cause or consequence of hypertension. Exp Biol Med 2001; 226: 619-620
21. Rodríguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Mezzano S, Vaziri ND. Early and sustained inhibition of nuclear factor kappa B prevents hypertension in spontaneously hypertensive rats. J Pharmacol Exp Ther (in press)
22. Kobori H, Nishiyama A, Abe Y, Navar LG. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on a high salt diet. Hypertension 2003; 41: 592-597
23. Franco M, Tapia E, Santamaria J et al. Renal cortical vasoconstriction contributes to the development of salt-sensitive hypertension after angiotensin II exposure. J Am Soc Nephrol 2001; 12: 2263-2271
24. Vaziri ND. Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 2004; 13: 93-99
25. Johnson RJ, Herrera-Acosta J, Schreiner G, Rodríguez-Iturbe B. Acquired and subtle renal injury as a mechanism for salt-sensitive hypertension: Bridging the hypothesis of Goldblatt and Guyton. N Engl J Med 2002; 346: 913-923
26. Johnson RJ, Rodriguez-Iturbe B, Kang DH, Feig DI, Herrera-Acosta J. A unifying pathway for essential hypertension. Am J Hypertens 2005; 18: 431-440
27. Rodriguez-Iturbe B, Quiroz Y, Kim CH, Vaziri ND. Hypertension induced by aortic coarctation above the renal arteries is associated with immune cell infiltration of the kidneys. Am J Hypertens (in press)
28. Sironi L, Gelosa P, Guerrini U et al. Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall. J Pharmacol Exp Ther 2004; 311: 989-995
29. Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int 2005; 67: 799-812
30. Touyz RM. Reactive oxygen species, vascular oxidative stress and redox signaling in hypertension. What is the clinical significance? Hypertension 2004; 44: 248-252